Mathai Mammen is of 10x Genomics, Inc.. Currently has a direct ownership of 180,259 shares of TXG, which is worth approximately $2.87 Million. The most recent transaction as insider was on Jun 11, 2024, when has been sold 8,649 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 180K
0% 3M change
5.04% 12M change
Total Value Held $2.87 Million

Mathai Mammen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
BUY
Grant, award, or other acquisition
-
8,649 Added 4.58%
180,259 Class A Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
1,865 Added 1.08%
171,610 Class A Common Stock
May 11 2023
SELL
Open market or private sale
$1,743,060 $52.82 p/Share
33,000 Reduced 16.28%
169,745 Class A Common Stock
May 11 2023
BUY
Exercise of conversion of derivative security
$231,999 $1.16 p/Share
200,000 Added 49.66%
202,745 Class A Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
2,120 Added 43.58%
2,745 Class A Common Stock
Jun 11 2021
BUY
Grant, award, or other acquisition
-
625 Added 50.0%
625 Class A Common Stock

Also insider at

JNJ
JOHNSON & JOHNSON Healthcare
MM

Mathai Mammen

New Brunswick, NJ

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG